National Biotechnology Initiative Act of 2025
The source supplies the latest action, but no lifecycle stage.
Latest action (19 Mar 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
What this bill does
# S. 1387 — National Biotechnology Initiative Act of 2025
This bill would establish a formal "National Biotechnology Initiative" led by the President through the Executive Office of the President, aimed at advancing national security, economic competitiveness, and productivity related to biotechnology. It would create an Interagency Committee—with representatives from agencies such as Defense, Commerce, Agriculture, Energy, Health and Human Services, and others—along with a new National Biotechnology Coordination Office to oversee planning. The Office's director, appointed by the President, would coordinate federal research funding, regulatory policy, biosecurity efforts, workforce development, and international partnerships related to biotechnology. The bill also directs creation of a public website consolidating federal biotechnology information and regulatory guidance, along with periodic reports to Congress and a national biotechnology strategy.
The bill primarily affects federal agencies, directing them to coordinate biotechnology-related activities, streamline overlapping regulations, and support workforce training and research funding. It would also affect businesses and researchers working with biotechnology products by aiming to clarify and simplify regulatory pathways, and it could indirectly affect the public through efforts to improve access to plain-language information about biotechnology. The Act authorizes federal appropriations—$22 million in fiscal year 2026 rising to $35 million in 2027, then $25 million annually through 2030—to support the Office's operations, administered through the National Science Foundation.
The bill was introduced in the Senate on April 9, 2025, by Senator Todd Young with Senator Padilla as a cosponsor, and referred to the Committee on Health, Education, Labor, and Pensions. It has not yet been voted on by the committee or the full Senate, and would need to pass both chambers of Congress and be signed by the President before taking effect.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
19 Mar 2026
Committee on Health, Education, Labor, and Pensions. Hearings held.
Common questions
- What does S. 1387 do?
- # S. 1387 — National Biotechnology Initiative Act of 2025 This bill would establish a formal "National Biotechnology Initiative" led by the President through the Executive Office of the President, aimed at advancing national security, economic competitiveness, and productivity related to biotechnology. It would create an Interagency Committee—with representatives from agencies such as Defense, Commerce, Agriculture, Energy, Health and Human Services, and others—along with a new National Biotechnology Coordination Office to oversee planning. The Office's director, appointed by the President, would coordinate federal research funding, regulatory policy, biosecurity efforts, workforce development, and international partnerships related to biotechnology. The bill also directs creation of a public website consolidating federal biotechnology information and regulatory guidance, along with periodic reports to Congress and a national biotechnology strategy. The bill primarily affects federal agencies, directing them to coordinate biotechnology-related activities, streamline overlapping regulations, and support workforce training and research funding. It would also affect businesses and researchers working with biotechnology products by aiming to clarify and simplify regulatory pathways, and it could indirectly affect the public through efforts to improve access to plain-language information about biotechnology. The Act authorizes federal appropriations—$22 million in fiscal year 2026 rising to $35 million in 2027, then $25 million annually through 2030—to support the Office's operations, administered through the National Science Foundation. The bill was introduced in the Senate on April 9, 2025, by Senator Todd Young with Senator Padilla as a cosponsor, and referred to the Committee on Health, Education, Labor, and Pensions. It has not yet been voted on by the committee or the full Senate, and would need to pass both chambers of Congress and be signed by the President before taking effect.
- Has S. 1387 become law?
- The source does not supply a confirmed lifecycle stage for S. 1387. Check the latest action and official source below.
- Who sponsored S. 1387?
- S. 1387 was sponsored by Sen. Young, Todd [R-IN] (R-IN), with 1 cosponsor.
- What's the latest action on S. 1387?
- Committee on Health, Education, Labor, and Pensions. Hearings held. (19 Mar 2026).
Related bills in Science, Technology, Communications
Disaster Communications Coordination and Preparedness Act
Mystic Alerts Act
Bots Research Act
Expressing support for the designation of October 5, 2026, as the "National Beyond the Milky Way Day" and celebrating a transformative achievement in American science.
More bills from Sen. Young, Todd [R-IN]
Protecting Biological Data as Critical Infrastructure Act
Federal Receivership Fairness Act
EGG SAVE Act of 2026
Build to Scale Reauthorization Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.